Moderna stockMRNA
Moderna trades at $241.46, 7.5% below its 52-week high (Nov 5, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +718.8% year to date, +924.9% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 6, 2026.
Ratings, candles, signals and the screener for MRNA — after you log in
Open the terminalFrequently asked questions about Moderna
What is the Moderna stock price?
At the close on Nov 5, 2026: $241.46 (−6.55% on the day). 52-week high: $261.00 on Nov 5, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Moderna report earnings?
The next quarterly report is on Nov 6, 2026. Last quarter, earnings per share changed +8% year over year, revenue +2%.
Does Moderna pay dividends?
No, Moderna does not pay dividends.
Where does Moderna trade and how to buy it?
Ticker MRNA, exchange Nasdaq, listed since 2018. You can buy it through a broker with access to US exchanges.
Should I buy Moderna now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for MRNA are in the terminal after you log in.